Mosaic trisomy 10

disease
On this page

Also known as chromosome 10, uniparental disomyMosaic trisomy chromosome 10Mosaic trisomy type 10trisomy 10 mosaicismuniparental disomy of 10

Summary

Mosaic trisomy 10 (MONDO:0019868) is a disease. A subtype of chromosome 10 disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families7WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Identifiers

Disease identifiers

FieldValue
Canonical namemosaic trisomy 10
Mondo IDMONDO:0019868
MeSHC538292
Orphanet96063
SNOMED CT764461004
UMLSC2931794
MedGen419163
GARD0019302
Is cancer (heuristic)no

Also known as: chromosome 10, uniparental disomy · mosaic trisomy 10 · Mosaic trisomy chromosome 10 · Mosaic trisomy type 10 · trisomy 10 mosaicism · uniparental disomy of 10

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › chromosomal disorder › autosomal anomaly › chromosome 10 disorder › mosaic trisomy 10

Related subtypes (3): ring chromosome 10, partial deletion of chromosome 10, partial duplication of chromosome 10

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.